Intellia Therapeutics, Inc. (NTLA) › Net IncomeIntellia Therapeutics, Inc. (NTLA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2015: -$12.40M2016: -$31.63M2017: -$67.54M2018: -$85.34M2019: -$474.19M2020: -$134.23M2021: -$267.89M2022: -$474.19M2023: -$481.19M2024: -$519.02M2025: -$412.69M-$412.69M2015Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$412.69M+20.5%2024-$519.02M-7.9%2023-$481.19M-1.5%2022-$474.19M-77.0%2021-$267.89M-99.6%2020-$134.23M+71.7%2019-$474.19M-455.6%2018-$85.34M-26.4%2017-$67.54M-113.5%2016-$31.63M-155.2%2015-$12.40M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share